Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. [electronic resource]
Producer: 20130927Description: 1432-9 p. digitalISSN:- 1549-4713
- Adolescent
- Adult
- Double-Blind Method
- Female
- Fingolimod Hydrochloride
- Fluorescein Angiography
- Humans
- Immunosuppressive Agents -- adverse effects
- Macular Edema -- chemically induced
- Male
- Middle Aged
- Multiple Sclerosis -- drug therapy
- Ophthalmoscopy
- Propylene Glycols -- adverse effects
- Sphingosine -- adverse effects
- Tomography, Optical Coherence
- Treatment Outcome
- Uveitis -- complications
- Visual Acuity -- physiology
- Young Adult
No physical items for this record
Publication Type: Case Reports; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.